Mon Aug 30, 2021 – 3:53 pm EDTMon Aug 30, 2021 – 3:56 pm EDT
TOKYO (LifeSiteNews) – In February, the chairman of the Tokyo Medical Association, Haruo Ozaki, called on Japanese doctors to implement ivermectin as an effective medication to combat COVID-19. About the usage of the anti-parasitic for COVID, given the international hesitancy to use it as a COVID medication, he said, “…We cannot say that ivermectin is absolutely not effective, at least not me.”
In an interview with the The Yomiuri Shimbun on August 5, Ozaki spoke in detail about his opinion that ivermectin should be used in Japan and said that his early calls for usage have seemingly not been heeded.
He stated that there is evidence from multiple countries that ivermectin has proven effective for patients diagnosed with COVID: “I am aware that there are many papers that ivermectin is effective in the prevention and treatment of [coronavirus], mainly in Central and South America and Asia.”
He also cited a paper examining the preventative effects of ivermectin regarding coronavirus infections in India. According to a study by a group of researchers at the All India Institute of Medical Sciences, “Participants who took ivermectin prophylaxis had a lower risk of getting symptoms suggestive of SARS-CoV-2 infection.”
The Indian study included 3532 health-care workers. According to the study,
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
